DexCom Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $2.04B | $1.05B |
| FY2022 | — | $2.13B | $642.3M |
| FY2023 | — | $2.07B | $566.3M |
| FY2024 | — | $2.10B | $606.1M |
| FY2025 | — | $2.75B | $917.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $2.04B | $1.05B |
| FY2022 | — | $2.13B | $642.3M |
| FY2023 | — | $2.07B | $566.3M |
| FY2024 | — | $2.10B | $606.1M |
| FY2025 | — | $2.75B | $917.7M |